{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:08:29Z","timestamp":1784297309104,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural\u2002Science\u2002Foundation\u2002of\u2002China","doi-asserted-by":"crossref","award":["82270197"],"award-info":[{"award-number":["82270197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural\u2002Science\u2002Foundation\u2002of\u2002China","doi-asserted-by":"crossref","award":["82270211"],"award-info":[{"award-number":["82270211"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The special project of \u201cTechnological innovation\u201d project of CNNC Medical Industry Co. Ltd","award":["ZHYLYB2021002"],"award-info":[{"award-number":["ZHYLYB2021002"]}]},{"DOI":"10.13039\/501100010023","name":"Natural Science Research of Jiangsu Higher Education Institutions of China","doi-asserted-by":"publisher","award":["BK20201408"],"award-info":[{"award-number":["BK20201408"]}],"id":[{"id":"10.13039\/501100010023","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00277-024-05670-7","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T05:05:01Z","timestamp":1709269501000},"page":"2905-2915","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A promising natural product in diffuse large B-cell lymphoma therapy by targeting PIM1"],"prefix":"10.1007","volume":"103","author":[{"given":"Xinyun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhuo","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingzong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"issue":"6769","key":"5670_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403(6769):503\u2013511","journal-title":"Nature"},{"issue":"1","key":"5670_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40291-022-00621-2","volume":"27","author":"H Chen","year":"2023","unstructured":"Chen H, Qin Y, Liu P et al (2023) Genetic profiling of diffuse large B-cell lymphoma: a comparison between double-expressor lymphoma and non-double-expressor lymphoma. Mol Diagn Ther 27(1):75\u201386","journal-title":"Mol Diagn Ther"},{"issue":"3","key":"5670_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/CM9.0000000000001294","volume":"134","author":"L Wang","year":"2020","unstructured":"Wang L, Li LR (2020) R-CHOP resistance in diffuse large B-cell lymphoma: biological and molecular mechanisms. Chin Med J (Engl) 134(3):253\u2013260","journal-title":"Chin Med J (Engl)"},{"key":"5670_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117866","volume":"255","author":"NK Panchal","year":"2020","unstructured":"Panchal NK, Sabina EP (2020) A serine\/threonine protein PIM kinase as a biomarker of cancer and a target for anti-tumor therapy. Life Sci 255:117866","journal-title":"Life Sci"},{"issue":"12","key":"5670_CR5","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1182\/blood-2017-01-760702","volume":"130","author":"M Szyd\u0142owski","year":"2017","unstructured":"Szyd\u0142owski M, Prochorec-Sobieszek M, Szumera-Cie\u0107kiewicz A et al (2017) Expression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma. Blood 130(12):1418\u20131429","journal-title":"Blood"},{"issue":"19","key":"5670_CR6","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1182\/blood-2009-03-212852","volume":"114","author":"LS Chen","year":"2009","unstructured":"Chen LS, Redkar S, Bearss D, Wierda WG, Gandhi V (2009) Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells. Blood 114(19):4150\u20134157","journal-title":"Blood"},{"issue":"23","key":"5670_CR7","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.1158\/0008-5472.CAN-21-1023","volume":"81","author":"M Szyd\u0142owski","year":"2021","unstructured":"Szyd\u0142owski M, Garbicz F, Jab\u0142o\u0144ska E et al (2021) Inhibition of PIM Kinases in DLBCL targets MYC transcriptional program and augments the efficacy of anti-CD20 antibodies. Cancer Res 81(23):6029\u20136043","journal-title":"Cancer Res"},{"issue":"7","key":"5670_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41589-019-0304-8","volume":"15","author":"JN Spradlin","year":"2019","unstructured":"Spradlin JN, Hu X, Ward CC et al (2019) Harnessing the anti-cancer natural product nimbolide for targeted protein degradation. Nat Chem Biol 15(7):747\u2013755","journal-title":"Nat Chem Biol"},{"key":"5670_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semcancer.2016.02.001","volume":"40\u201341","author":"NS Yarla","year":"2016","unstructured":"Yarla NS, Bishayee A, Sethi G et al (2016) Targeting arachidonic acid pathway by natural products for cancer prevention and therapy. Semin Cancer Biol 40\u201341:48\u201381","journal-title":"Semin Cancer Biol"},{"key":"5670_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/413076","volume":"2015","author":"NC Kampan","year":"2015","unstructured":"Kampan NC, Madondo MT, McNally OM, Quinn M, Plebanski M (2015) Paclitaxel and its evolving role in the management of ovarian cancer. Biomed Res Int 2015:413076","journal-title":"Biomed Res Int"},{"issue":"2","key":"5670_CR11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41375-020-0766-4","volume":"35","author":"KT Hartert","year":"2021","unstructured":"Hartert KT, Wenzl K, Krull JE et al (2021) Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL. Leukemia 35(2):522\u2013533","journal-title":"Leukemia"},{"issue":"11","key":"5670_CR12","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1016\/j.chroma.2008.09.070","volume":"1216","author":"Y Lu","year":"2009","unstructured":"Lu Y, Chen DF (2009) Analysis of Schisandra chinensis and Schisandra sphenanthera. J Chromatogr A 1216(11):1980\u20131990","journal-title":"J Chromatogr A"},{"issue":"11","key":"5670_CR13","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/nm.4213","volume":"22","author":"D Horiuchi","year":"2016","unstructured":"Horiuchi D, Camarda R, Zhou AY et al (2016) PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression. Nat Med 22(11):1321\u20131329","journal-title":"Nat Med"},{"issue":"35","key":"5670_CR14","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1038\/onc.2008.123","volume":"27","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Wang Z, Li X, Magnuson NS (2008) Pim kinase-dependent inhibition of c-Myc degradation. Oncogene 27(35):4809\u20134819","journal-title":"Oncogene"},{"issue":"1","key":"5670_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI73939","volume":"125","author":"YC Kim","year":"2015","unstructured":"Kim YC, Guan KL (2015) mTOR: a pharmacologic target for autophagy regulation. J Clin Invest 125(1):25\u201332","journal-title":"J Clin Invest"},{"key":"5670_CR16","doi-asserted-by":"crossref","unstructured":"Kabeya Y, Mizushima N, Ueno T et al (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. Embo J 19(21):5720\u20135728","DOI":"10.1093\/emboj\/19.21.5720"},{"issue":"13","key":"5670_CR17","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-3338","volume":"77","author":"LM Colli","year":"2017","unstructured":"Colli LM, Machiela MJ, Zhang H et al (2017) Landscape of combination immunotherapy and targeted therapy to improve cancer management. Cancer Res 77(13):3666\u20133671","journal-title":"Cancer Res"},{"key":"5670_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102443","volume":"110","author":"S Poletto","year":"2022","unstructured":"Poletto S, Novo M, Paruzzo L, Frascione PMM, Vitolo U (2022) Treatment strategies for patients with diffuse large B-cell lymphoma. Cancer Treat Rev 110:102443","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"5670_CR19","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1111\/jcmm.16289","volume":"25","author":"X Xie","year":"2021","unstructured":"Xie X, Wang X, Shi X et al (2021) Anwulignan is a novel JAK1 inhibitor that suppresses non-small cell lung cancer growth. J Cell Mol Med 25(5):2645\u20132654","journal-title":"J Cell Mol Med"},{"issue":"7684","key":"5670_CR20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature25016","volume":"552","author":"Z Skrott","year":"2017","unstructured":"Skrott Z, Mistrik M, Andersen KK et al (2017) Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature 552(7684):194\u2013199","journal-title":"Nature"},{"issue":"1","key":"5670_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41589-019-0424-1","volume":"16","author":"NT Ross","year":"2020","unstructured":"Ross NT, Lohmann F, Carbonneau S et al (2020) CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing\u2019s sarcoma. Nat Chem Biol 16(1):50\u201359","journal-title":"Nat Chem Biol"},{"issue":"7","key":"5670_CR22","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1182\/bloodadvances.2018027227","volume":"3","author":"R Buettner","year":"2019","unstructured":"Buettner R, Morales C, Caserta E et al (2019) Leflunomide regulates c-Myc expression in myeloma cells through PIM targeting. Blood Adv 3(7):1027\u20131032","journal-title":"Blood Adv"},{"key":"5670_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12943-015-0477-z","volume":"14","author":"S Kreuz","year":"2015","unstructured":"Kreuz S, Holmes KB, Tooze RM, Lefevre PF (2015) Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas. Mol Cancer 14:205","journal-title":"Mol Cancer"},{"issue":"1","key":"5670_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40164-023-00383-5","volume":"12","author":"S Gu","year":"2023","unstructured":"Gu S, Hou Y, Dovat K, Dovat S, Song C, Ge Z (2023) Synergistic effect of HDAC inhibitor chidamide with cladribine on cell cycle arrest and apoptosis by targeting HDAC2\/c-Myc\/RCC1 axis in acute myeloid leukemia. Exp Hematol Oncol 12(1):23","journal-title":"Exp Hematol Oncol"},{"issue":"8","key":"5670_CR25","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1631\/jzus.B2200016","volume":"23","author":"C Luo","year":"2022","unstructured":"Luo C, Yu T, Young KH, Yu L (2022) HDAC inhibitor chidamide synergizes with venetoclax to inhibit the growth of diffuse large B-cell lymphoma via down-regulation of MYC, BCL2, and TP53 expression. J Zhejiang Univ Sci B 23(8):666\u2013681","journal-title":"J Zhejiang Univ Sci B"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05670-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05670-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05670-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T06:05:36Z","timestamp":1722060336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05670-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["5670"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05670-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"assertion":[{"value":"9 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experimentation acquired permission from the ethics committee of Soochow university. The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}